State Health Investment Project: Impact Evaluation Endline Survey, 2017

Nigeria, 2017

Get Microdata

Reference ID

NGA_2017_HRBFIE-EL_v01_M

Producer(s)

Eeshani Kandpal (World Bank)

Metadata

DDI/XML JSON

Study website

Created on

Dec 05, 2022

Last modified

Aug 28, 2024

Page views

101045

Downloads

313

Data file: anc_patients_noid.dta

This file contains data from the Patient Direct Observation (HF3/HF4) Questionnaire:
- Antenatal care

Cases:	5360
Variables:	215

Variables

int_start_time

Start Time

HF3_Q102A

Patient Age Year

HF3_Q102B

2.02b. How many antenatal visits has the patient have before this visit?

HF3_Q102C

2.02c: Was at least one of those antenatal visits at this clinic?

HF3_Q102D

A.Time of Patient Arrival at the registration/records area

HF3_Q103

2.03 : TIME OF ENTRY IN THE CONSULTATION ROOM

HF3_Q104

2.04 : TIME WHEN SERVICE PROVISION STARTED

HF3_Q109

2.09 : DID THE HEALTH CARE PROVIDER INTRODUCE HIMSELF OR HERSELF TO THE PATIENT?

HF3_Q110

2.10 : WAS THERE ANY OTHER PATIENTS PRESENT IN THE CONSULTATION ROOM

HF3_Q111

2.11 : ANY OTHER PERSON PRESENT IN THE CONSULTATION ROOM AT THE TIME?

HF3_Q112

2.12 : WHO ELSE WAS PRESENT THERE OTHER THAN THE PATIENT, HEALTHCARE PROVIDER A

HF3_Q113

2.13 : IF THIS WAS THE CLIENT'S FIRST VISIT FOR ANTENATAL CARE AT THIS FACILITY

HF3_Q114

2.14 : IF THIS WAS THE CLIENT'S FIRST PREGNANCY

HF3_Q115

2.15 : THE CLIENT'S OR PATIENT'S AGE

HF3_Q116

2.16 : MEDICATION CURRENTLY BEING TAKEN

HF3_Q117

2.17 : THE DATE THE PATIENT'S LAST MENSTRUAL PERIOD BEGAN

HF3_Q118

2.18 : THE NUMBER OF PRIOR PREGENANCIES THE CLIENT HAS HAD

HF3_Q119

2.19 : PRIOR STILL BIRTHS IF ANY

HF3_Q120

2.20 : INFANT(S) WHO DIED IN THE FIRST WEEK OF LIFE

HF3_Q121

2.21 : HEAVY BLEEDING DURING OR AFTER DELIVERY

HF3_Q122

2.22 : PREVIOUS ASSISTED DELIVERY (CAESAREAN SECTION,VACUUM OR FORCEPS)

HF3_Q123

2.23 : PREVIOUS ABORTIONS

HF3_Q124

2.24 : BLEEDING

HF3_Q125

2.25 : FEVER

HF3_Q126

2.26 : HEADACHE OR BLURRED VISION

HF3_Q127

2.27 : SWOLLEN FACE OR HANDS

HF3_Q128

2.28 : TIREDNESS OR BREATHLESSNESS

HF3_Q129

2.29 : WHETHER CLIENT FELT THE BABY MOVE

HF3_Q130

2.30 : ANY OTHER SYMPTOMS OR PROBLEMS

HF3_Q131

2.31 : SYMPTOMS THE CLIENT THINKS MIGHT BE RELATED TO THIS PREGNANCY

HF3_Q132

2.32 : TAKE BLOOD PRESSURE OF THE CLIENT

HF3_Q133

2.33 : WEIGH THE CLIENT

HF3_Q134

2.34 : EXAMINE FOR ANAEMIA

HF3_Q135

2.35 : EXAMINE LEGS/FEET FOR OEDEMA

HF3_Q136

2.36 : PALPATE CLIENT'S ABDOMEN FOR FETAL PRESENTATION (OR CONDUCT ULTRASOUND)

HF3_Q137

2.37 : PALPATE THE CLIENT'S ABDOMEN FOR UTERINE HEIGHT (OR CONDUCT ULTRASOUND)

HF3_Q138

2.38 : LISTEN TO THE CLIENT'S ABDOMEN FOR FETAL HEARTBEAT

HF3_Q139

2.39 : EXAMINE THE CLIENT'S BREASTS

HF3_Q140

2.40 : CONDUCT VAGINAL EXAMINATION/EXAM OF PERINEAL AREA

HF3_Q141

1.41 : PERFORM OR REFER FOR ANAEMIA TEST

HF3_Q142

2.42 : PERFORM OR REFER FOR URINE TEST

HF3_Q143

2.43 : PERFORM OR REFER THE CLIENT FOR SYPHILIS TEST

HF3_Q144

2.44 : PERFORM OR REFER FOR HIV TEST

HF3_Q145

2.45 : PROVIDE OR REFER FOR COUNSELLING RELATED TO HIV TEST (IF HIV POSITIVE)

HF3_Q146

2.46 :LOOK AT THE CLIENT'S HEALTH CARD (EITHER BEFORE BEGINNING THE CONSULTATION

HF3_Q147

2.47 : PRESCRIBED/GAVE IRON PILLS (TABLETS) OR FOLIC ACID OR BOTH

HF3_Q148

2.48 : EXPLAINED THE PURPOSE OF IRON OR FOLIC ACID

HF3_Q149

2.49 : EXPLAINED HOW TO TAKE IRON OR FOLIC-ACID PILLS (TABLETS)

HF3_Q150

2.50 : EXPLAINED SIDE EFFECTS OF IRON PILLS

HF3_Q151

2.51 :PRESCRIBED OR GAVE A TETANUS TOXOID (TT) INJECTION

HF3_Q152

2.52 : EXPLAINED THE PURPOSE OF THE TT INJECTION

HF3_Q153

2.53 : PRESCRIBED/ GAVE ANTI-MALARIAL PROPHYLAXIS

HF3_Q154

2.54 : EXPLAINED CORRECTLY THE PURPOSE OF THE PREVENTIVE TREATMENT WITH MALARIA

HF3_Q155

2.55 : EXPLAINED HOW TO TAKE ANTI-MALARIAL MEDICATION

HF3_Q156

2.56 : EXPLAINED POSSIBLE SIDE EFFECTS OF MALARIA PILLS

HF3_Q157

2.57 : OBSERVED THAT THE 1ST DOSE OF INTERMITTENT PREVENTIVE THERAPY (IPT) IS GI

HF3_Q158

2.58 : IMPORTANCE OF A SECOND DOSE OF IPT EXPLAINED

HF3_Q159

2.59 : IMPORTANCE OF USING INSECTICIDE TREATED NETS (ITN) EXPLAINED EXPLICITLY

HF3_Q160

2.60 : GIVEN VOUCHER FOR ITN/GIVEN ITN FREE OF CHARGE

HF3_Q161

2.61 : ITN PURCHASED BY THE CLIENT

HF3_Q162

2.62 : DISCUSSED QUANTITY OR QUALITY OF FOOD TO EAT DURING PREGNANCY

HF3_Q163

2.63 : VAGINAL BLEEDING

HF3_Q164

2.64 : FEVER

HF3_Q165

2.65 : EXCESSIVE TIREDNESS OR BREATHLESSNESS

HF3_Q166

2.66 : SWOLLEN HANDS AND FACE

HF3_Q167

2.67 : SEVERE HEADACHE OR BLURRED VISION

HF3_Q168

2.68 : INFORMED THE CLIENT ABOUT THE PROGRESS OF THE PREGNANCY

HF3_Q169

2.69 : ASKED THE CLIENT WHERE SHE WILL DELIVER

HF3_Q170

2.70 : ADVISED THE CLIENT TO PREPARE FOR DELIVERY (E.G. SET ASIDE MONEY, ARRANGE

HF3_Q171

2.71 : ADVISED THE CLIENT TO USE A SKILLED HEALTH WORKER DURING DELIVERY

HF3_Q172

2.72 : DISCUSSED WITH CLIENT WHAT ITEMS TO HAVE ON HAND AT HOME FOR DELIVERY (IN

HF3_Q173

2.73 : DISCUSSED IMPORTANCE OF IMMUNISATION FOR THE NEWBORN

HF3_Q174

2.74 RECORD WHETHER THE PROVIDER ADVISED EXCLUSIVELY BREASTFEEDING THE IN

HF3_Q175

2.75 : RECORD WHETHER THE PROVIDER DISCUSSED FAMILY PLANNING (OR BIRTH C

HF3_Q176

2.76 : RECORD WHETHER THE PROVIDER ASKED WHETHER THE CLIENT HAD ANY QUESTIONS AN

HF3_Q177

2.77 : RECORD WHETHER THE PROVIDER USED ANY VISUAL AIDS FOR HEALTH EDUCATION OR

HF3_Q178

2.78 : RECORD WHETHER THE PROVIDER WROTE ON THE CLIENT'S HEALTH CARD

HF3_Q179

2.79 : RECORD HOW MANY WEEKS PREGNANT THE CLIENT IS.

HF3_Q180

2.80 : RECORD THE OUTCOME OF THE CONSULTATION

HF3_Q181

2.81 : TIME CONSULTATION ENDED WITH THIS PROVIDER

HF3_Q182

2.82 : WHERE DID THE PATIENT GO AFTER EXITING THIS CONSULTATION?

HF3_Q203

2.03 : TIME OF ENTRY IN THE CONSULTATION ROOM

HF3_Q204

2.04 : TIME WHEN SERVICE PROVISION STARTED

HF3_Q209

2.09 : DID THE HEALTH CARE PROVIDER INTRODUCE HIMSELF OR HERSELF TO THE PATIENT?

HF3_Q210

2.10 : WAS THERE ANY OTHER PATIENTS PRESENT IN THE CONSULTATION ROOM

HF3_Q211

2.11 : ANY OTHER PERSON PRESENT IN THE CONSULTATION ROOM AT THE TIME?

HF3_Q212

2.12 : WHO ELSE WAS PRESENT THERE OTHER THAN THE PATIENT, HEALTHCARE PROVIDER A

HF3_Q224

2.24 : BLEEDING

HF3_Q225

2.25 : FEVER

HF3_Q226

2.26 : HEADACHE OR BLURRED VISION

HF3_Q227

2.27 : SWOLLEN FACE OR HANDS

HF3_Q228

2.28 : TIREDNESS OR BREATHLESSNESS

HF3_Q229

2.29 : WHETHER CLIENT FELT THE BABY MOVE

HF3_Q230

2.30 : ANY OTHER SYMPTOMS OR PROBLEMS

HF3_Q231

2.31 : SYMPTOMS THE CLIENT THINKS MIGHT BE RELATED TO THIS PREGNANCY

HF3_Q234

2.34 : EXAMINE FOR ANAEMIA

HF3_Q235

2.35 : EXAMINE LEGS/FEET FOR OEDEMA

HF3_Q236

2.36 : PALPATE CLIENT'S ABDOMEN FOR FETAL PRESENTATION (OR CONDUCT ULTRASOUND)

HF3_Q237

2.37 : PALPATE THE CLIENT'S ABDOMEN FOR UTERINE HEIGHT (OR CONDUCT ULTRASOUND)

HF3_Q238

2.38 : LISTEN TO THE CLIENT'S ABDOMEN FOR FETAL HEARTBEAT

HF3_Q239

2.39 : EXAMINE THE CLIENT'S BREASTS

HF3_Q240

2.40 : CONDUCT VAGINAL EXAMINATION/EXAM OF PERINEAL AREA

HF3_Q241

2.41 : PERFORM OR REFER FOR ANAEMIA TEST

HF3_Q242

2.42 : PERFORM OR REFER FOR URINE TEST

HF3_Q243

2.43 : PERFORM OR REFER THE CLIENT FOR SYPHILIS TEST

HF3_Q244

2.44 : PERFORM OR REFER FOR HIV TEST

HF3_Q245

2.45 : PROVIDE OR REFER FOR COUNSELLING RELATED TO HIV TEST (IF HIV POSITIVE)

HF3_Q246

2.46 :LOOK AT THE CLIENT'S HEALTH CARD (EITHER BEFORE BEGINNING THE CONSULTATION

HF3_Q247

2.47 : PRESCRIBED/GAVE IRON PILLS (TABLETS) OR FOLIC ACID OR BOTH

HF3_Q248

2.48 : EXPLAINED THE PURPOSE OF IRON OR FOLIC ACID

HF3_Q249

2.49 : EXPLAINED HOW TO TAKE IRON OR FOLIC-ACID PILLS (TABLETS)

HF3_Q250

2.50 : EXPLAINED SIDE EFFECTS OF IRON PILLS

HF3_Q251

2.51 :PRESCRIBED OR GAVE A TETANUS TOXOID (TT) INJECTION

HF3_Q252

2.52 : EXPLAINED THE PURPOSE OF THE TT INJECTION

HF3_Q253

2.53 : PRESCRIBED/ GAVE ANTI-MALARIAL PROPHYLAXIS

HF3_Q254

2.54 : EXPLAINED CORRECTLY THE PURPOSE OF THE PREVENTIVE TREATMENT WITH MALARIA

HF3_Q255

2.55 : EXPLAINED HOW TO TAKE ANTI-MALARIAL MEDICATION

HF3_Q256

2.56 : EXPLAINED POSSIBLE SIDE EFFECTS OF MALARIA PILLS

HF3_Q257

2.57 : OBSERVED THAT THE 1ST DOSE OF INTERMITTENT PREVENTIVE THERAPY (IPT) IS GI

HF3_Q258

2.58 : IMPORTANCE OF A SECOND DOSE OF IPT EXPLAINED

HF3_Q259

2.59 : IMPORTANCE OF USING INSECTICIDE TREATED NETS (ITN) EXPLAINED EXPLICITLY

HF3_Q260

2.60 : GIVEN VOUCHER FOR ITN/GIVEN ITN FREE OF CHARGE

HF3_Q261

2.61 : ITN PURCHASED BY THE CLIENT

HF3_Q262

2.62 : DISCUSSED QUANTITY OR QUALITY OF FOOD TO EAT DURING PREGNANCY

HF3_Q263

2.63 : VAGINAL BLEEDING

HF3_Q264

2.64 : FEVER

HF3_Q265

2.65 : EXCESSIVE TIREDNESS OR BREATHLESSNESS

HF3_Q266

2.66 : SWOLLEN HANDS AND FACE

HF3_Q267

2.67 : SEVERE HEADACHE OR BLURRED VISION

HF3_Q268

2.68 : INFORMED THE CLIENT ABOUT THE PROGRESS OF THE PREGNANCY

HF3_Q269

2.69 : ASKED THE CLIENT WHERE SHE WILL DELIVER

HF3_Q270

2.70 : ADVISED THE CLIENT TO PREPARE FOR DELIVERY (E.G. SET ASIDE MONEY, ARRANGE

HF3_Q271

2.71 : ADVISED THE CLIENT TO USE A SKILLED HEALTH WORKER DURING DELIVERY

HF3_Q272

2.72 : DISCUSSED WITH CLIENT WHAT ITEMS TO HAVE ON HAND AT HOME FOR DELIVERY (IN

HF3_Q273

2.73 : DISCUSSED IMPORTANCE OF IMMUNISATION FOR THE NEWBORN

HF3_Q274

2.74 RECORD WHETHER THE PROVIDER ADVISED EXCLUSIVELY BREASTFEEDING THE IN

HF3_Q275

2.75 : RECORD WHETHER THE PROVIDER DISCUSSED FAMILY PLANNING (OR BIRTH C

HF3_Q276

2.76 : RECORD WHETHER THE PROVIDER ASKED WHETHER THE CLIENT HAD ANY QUESTIONS AN

HF3_Q277

2.77 : RECORD WHETHER THE PROVIDER USED ANY VISUAL AIDS FOR HEALTH EDUCATION OR

HF3_Q278

2.78 : RECORD WHETHER THE PROVIDER WROTE ON THE CLIENT'S HEALTH CARD

HF3_Q279

2.79 : RECORD HOW MANY WEEKS PREGNANT THE CLIENT IS.

HF3_Q280

2.80 : RECORD THE OUTCOME OF THE CONSULTATION

HF3_Q281

2.81 : TIME CONSULTATION ENDED WITH THIS PROVIDER

HF3_Q282

2.82 : WHERE DID THE PATIENT GO AFTER EXITING THIS CONSULTATION?

HF3_Q303

3.03 : LAB WORK DONE TODAY?

HF3_Q304

3.04 : TIME WHEN THE PATIENT ARRIVED AT LABORATORY AREA FOR SERVICE?

HF3_Q305

3.05 : TIME WHEN A PROVIDER STARTED TO PROVIDE SERVICES IN THE LAB

HF3_Q310

3.10 : DID THE HEALTH WORKER INTRODUCE HIMSELF OR HERSELF TO THE PATIENT?

HF3_Q311

3.11 : DID THE HEALTH WORKER LET THE PATIENT KNOW WHAT HE/SHE WILL BE DOING IN T

HF3_Q312

3.12 : DID HEALTH WORKER COLLECT BLOOD FOR TESTING?

HF3_Q313

3.13 : DID HEALTH WORKER COLLECT URINE FOR TESTING?

HF3_Q314

DID THE HEALTH WORKER WRITE THE NAME OF THE PATIENT ON THE SPECIMEN COLLECTED?

HF3_Q315

3.15 : DID THE HEALTH WORKER TELL THE PATIENT WHEN THE TEST RESULTS WILL BE

HF3_Q316

3.16 : DID THE HEALTH WORKER EXPLAIN THE PURPOSE OF THE LAB TESTS?

HF3_Q317

3.17 : IF SYRINGE WAS USED, DID THE HEALTH WORKER USE A NEW SYRINGE?

HF3_Q318

3.18 : WAS THE COTTON AND OTHER SUPPLIES USED CLEAN/STERILIZED?

HF3_Q319

3.19 : DID THE HEALTH WORKER USE STERILIZED HAND GLOVES?

HF3_Q320

3.20 : TIME PATIENT EXITED THE LAB

HF3_Q321

3.21 : WHERE DID THE PATIENT GO NEXT AFTER LAB SERVICES?

HF3_Q403

4.03 :TDRUGS OBTAINED TODAY?

HF3_Q404

4.04 :TIME WHEN THE PATIENT ARRIVED AT PHARMACY OR STORE AREA FOR SERVICE

HF3_Q409

4.09 : IS THERE A QUEUE TO GET DRUGS?

HF3_Q410

4.10 : AT WHAT TIME DID THE PHARMACY STORE PERSON START PROVIDING SERVICE TO

HF3_Q411

4.11 : DID THE HEALTH WORKER ASK FOR THE PRESCRIPTION FROM THE PATIENT?

HF3_Q412

4.12 : DID HEALTH WORKER LET THE PATIENT KNOW IF THE FACILITY HAS ALL THE DRUGS

HF3_Q413

4.13 : DID HEALTH WORKER LET THE PATIENT KNOW PRICE OF EACH OF THE DRUGS?

HF3_Q414

4.14 : WAS THE HEALTH WORKER RESPECTFUL TOWARDS THE PATIENT?

HF3_Q415

4.15 : DID THE HEALTH WORKER RESPOND TO ALL THE QUESTIONS THE PATIENT

HF3_Q416

4.16 : DID THE HEALTHCARE WORKER EXPLAIN THE NUMBER OF TIMES THE DRUGS SHOULD

HF3_Q417

4.17 : DID THE HEALTHCARE WORKER MENTION HOW LONG EACH OF THE MEDICINES SHOULD

HF3_Q418

4.18 :DID THE HEALTHCARE PROVIDER DISCUSS POTENTIAL SIDE EFFECTS OF THE DRUGS?

HF3_Q419

4.19 : HOW MANY DRUGS WERE PRESCRIBED TO THE PATIENT TODAY? (ASK DRUG DISOENSER

HF3_Q420

4.20 : HOW MANY DRUGS DID THE PATIENT BUY OR GET TODAY?(ASK THE DRUG DISPENSER)

HF3_Q421

4.21 : DID THE PROVIDER PRESCRIBE ANY ANTIBIOTICS TO THE PATIENT TODAY?

HF3_Q422

4.22 : HOW MANY ANTIBIOTICS WERE PRESCRIBED?

HF3_Q423

4.23 : TIME WHEN THE PATIENT RECEIVED THE DRUGS AND EXITED THE PHARMACY AREA

HF3_Q424

4.24 : WHERE DID THE PATIENT GO NEXT AFTER PHARMACY SERVICES?

HF3_Q503

5.03 : DIAGNOSTIC TESTS DONE TODAY?

HF3_Q504

5.04 : TIME WHEN THE PATIENT ARRIVED AT DIAGNOSTIC TEST AREA FOR SERVICE

HF3_Q509

5.09 : AT WHAT TIME HEALTH WORKER STARTED PROVIDING SERVICE TO PATIENT?

HF3_Q510

5.10 : DID THE HEALTH WORKER ASK FOR THE DIAGNOSTIC TEST ORDER AND/OR RECEIVED

HF3_Q511__1

5.11 : LIST THE TESTS ORDERED BY HEALTH CARE PROVIDER:CHEST X-RAY

HF3_Q511__2

5.11 : LIST THE TESTS ORDERED BY HEALTH CARE PROVIDER:OTHER X-RAY

HF3_Q511__3

5.11 : LIST THE TESTS ORDERED BY HEALTH CARE PROVIDER:ECG

HF3_Q511__4

5.11 : LIST THE TESTS ORDERED BY HEALTH CARE PROVIDER:ULTRASOUND

HF3_Q511__5

5.11 : LIST THE TESTS ORDERED BY HEALTH CARE PROVIDER:MEMOGRAMS

HF3_Q511__6

5.11 : LIST THE TESTS ORDERED BY HEALTH CARE PROVIDER:OTHER TESTS

HF3_Q511_other

5.11 : SPECIFY OTHER TESTS

HF3_Q512

5.12 : WERE ALL THE TESTS ORDERED BY HEALTHCARE PROVIDER DONE FOR THE PATIENT?

HF3_Q513__1

5.13A. NO ELECTRICITY:NO ELECTRICITY

HF3_Q513__2

5.13A. NO ELECTRICITY:NO MACHINE

HF3_Q513__3

5.13A. NO ELECTRICITY:MACHINE NOT WORKING

HF3_Q513__4

5.13A. NO ELECTRICITY:SUPPLIES NEEDED FOR TEST

HF3_Q513__5

5.13A. NO ELECTRICITY:NOT AVAILABLE

HF3_Q513__6

5.13A. NO ELECTRICITY:PATIENT DID NOT WANT

HF3_Q513__7

5.13A. NO ELECTRICITY:OTHERS SPECIFY

HF3_Q513_other

5.13: OTHER REASONS SPECIFY FOR DOING THE TESTS

HF3_Q514

5.14 : DID THE HEALTH WORKER ENSURE THAT THE TEST RESULT CAN BE MATCHED WITH

HF3_Q515

5.15 : DID THE HEALTH WORKER ADOPT SAFETY MEASURES FOR THE SAFETY OF BOTH

HF3_Q516

5.16 : DID THE HEALTH WORKER BEHAVE WELL WITH THE PATIENT?

HF3_Q517

5.17 : DID THE HEALTH WORKER ASK THE PATIENT IF THEY HAVE

HF3_Q518

5.18 : DID THE PATIENT ASK ANY QUESTION IN RESPONSE?

HF3_Q519

5.19 : DID THE HEALTH WORKER RESPOND TO THE QUESTIONS?

HF3_Q520

5.20 : DID THE HEALTH WORKER TELL THE PATIENT WHAT TESTS WILL BE

HF3_Q521

5.21 : DID THE HEALTH WORKER EXPLAIN THE STEPS TO BE FOLLOWED FOR THE TEST?

HF3_Q522

5.22 : DID THE HEALTH WORKER INFORMED THE PATIENT WHEN THE RESULTS

HF3_Q523

5.23 : DID HEALTH WORKER USE PROTECTIVE JACKET FOR X-RAYS?

HF3_Q524

5.24 : DID HEALTH WORKER USE CLEAN SUPPLIES FOR DOING DIAGNOSTIC TESTS

HF3_Q525

5.25 : WAS THE PRINTOUT OF ECG CLEAR?

HF3_Q526

5.26 : WAS THE PRINTOUT OF ULTRASOUND CLEAR?

HF3_Q527

5.27 : DID THE HEALTH WORKER TELL THE PATIENT THE COST

HF3_Q528

5.28 : TIME WHEN THE PATIENT COMPLETED THE TESTS AND EXITED THE AREA

HF3_Q529

5.29 : WHERE DID THE PATIENT GO NEXT AFTER DIAGNOSTIC TESTS?

ParentId1

InterviewId

Total: 215

Back to Catalog